Anne S. Hellkamp

1.1k total citations
24 papers, 678 citations indexed

About

Anne S. Hellkamp is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Anne S. Hellkamp has authored 24 papers receiving a total of 678 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in Anne S. Hellkamp's work include Cardiac pacing and defibrillation studies (7 papers), Heart Failure Treatment and Management (7 papers) and Cardiovascular Function and Risk Factors (6 papers). Anne S. Hellkamp is often cited by papers focused on Cardiac pacing and defibrillation studies (7 papers), Heart Failure Treatment and Management (7 papers) and Cardiovascular Function and Risk Factors (6 papers). Anne S. Hellkamp collaborates with scholars based in United States, United Kingdom and Germany. Anne S. Hellkamp's co-authors include Laine Thomas, Jonathan P. Piccini, Yuliya Lokhnygina, Werner Hacke, Daniel E. Singer, Christopher C. Nessel, Kenneth W. Mahaffey, Jonathan L. Halperin, Manesh R. Patel and Keith A.A. Fox and has published in prestigious journals such as Journal of the American College of Cardiology, European Heart Journal and American Heart Journal.

In The Last Decade

Anne S. Hellkamp

23 papers receiving 667 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne S. Hellkamp United States 15 556 89 71 64 58 24 678
Franz Goss Germany 8 1.1k 2.0× 59 0.7× 42 0.6× 76 1.2× 66 1.1× 22 1.2k
Takehiko Keida Japan 12 492 0.9× 80 0.9× 42 0.6× 26 0.4× 26 0.4× 30 566
Satoshi Higuchi Japan 13 373 0.7× 72 0.8× 90 1.3× 19 0.3× 64 1.1× 63 490
Sergio Cannizzaro Italy 13 411 0.7× 64 0.7× 63 0.9× 117 1.8× 48 0.8× 31 519
Yu Jie Zhou China 12 425 0.8× 54 0.6× 28 0.4× 80 1.3× 113 1.9× 29 596
Fred Kueffer United States 14 1.3k 2.3× 161 1.8× 68 1.0× 53 0.8× 71 1.2× 35 1.4k
Ezgi Kalaycıoğlu Türkiye 13 316 0.6× 114 1.3× 32 0.5× 74 1.2× 75 1.3× 58 475
W. Kamke Germany 9 622 1.1× 77 0.9× 51 0.7× 84 1.3× 56 1.0× 17 759
P D Batin United Kingdom 11 446 0.8× 92 1.0× 27 0.4× 14 0.2× 93 1.6× 15 537
Pil‐Sung Yang South Korea 11 472 0.8× 22 0.2× 108 1.5× 47 0.7× 29 0.5× 42 598

Countries citing papers authored by Anne S. Hellkamp

Since Specialization
Citations

This map shows the geographic impact of Anne S. Hellkamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne S. Hellkamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne S. Hellkamp more than expected).

Fields of papers citing papers by Anne S. Hellkamp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne S. Hellkamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne S. Hellkamp. The network helps show where Anne S. Hellkamp may publish in the future.

Co-authorship network of co-authors of Anne S. Hellkamp

This figure shows the co-authorship network connecting the top 25 collaborators of Anne S. Hellkamp. A scholar is included among the top collaborators of Anne S. Hellkamp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne S. Hellkamp. Anne S. Hellkamp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Todd, Jamie L., Megan L. Neely, Anne S. Hellkamp, et al.. (2025). Changes in Lung Function and Patient-Reported Outcomes in Patients with Idiopathic Pulmonary Fibrosis. Lung. 203(1). 90–90.
2.
Harrington, Josephine, Anne S. Hellkamp, Kenneth W. Mahaffey, et al.. (2024). Assessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF Analysis. Journal of the American Heart Association. 13(11). e028951–e028951. 1 indexed citations
3.
Hellkamp, Anne S., Megan L. Neely, John M. Reynolds, et al.. (2024). Basiliximab induction immunosuppression and lung transplant outcomes: Propensity analysis in a multicenter cohort. The Journal of Heart and Lung Transplantation. 44(6). 950–960. 1 indexed citations
4.
Andrade, João A. de, Megan L. Neely, Anne S. Hellkamp, et al.. (2023). Effect of Antifibrotic Therapy on Survival in Patients With Idiopathic Pulmonary Fibrosis. Clinical Therapeutics. 45(4). 306–315. 16 indexed citations
5.
Segar, Matthew W., Kershaw V. Patel, Anne S. Hellkamp, et al.. (2022). Validation of the WATCH‐DM and TRS‐HF DM Risk Scores to Predict the Risk of Incident Hospitalization for Heart Failure Among Adults With Type 2 Diabetes: A Multicohort Analysis. Journal of the American Heart Association. 11(11). 20 indexed citations
6.
Hellkamp, Anne S., Laine Thomas, Nancy M. Albert, et al.. (2022). Angiotensin Receptor Neprilysin Inhibition and Associated Outcomes by Race and Ethnicity in Patients With Heart Failure With Reduced Ejection Fraction: Data From CHAMP‐HF. Journal of the American Heart Association. 11(12). e022889–e022889. 4 indexed citations
7.
Khan, Muhammad Shahzeb, Stephen J. Greene, Anne S. Hellkamp, et al.. (2021). Diuretic Changes, Health Care Resource Utilization, and Clinical Outcomes for Heart Failure With Reduced Ejection Fraction: From the Change the Management of Patients With Heart Failure Registry. Circulation Heart Failure. 14(11). e008351–e008351. 21 indexed citations
8.
Loring, Zak, Anne S. Hellkamp, Brett D. Atwater, et al.. (2020). VVI pacing with normal QRS duration and ventricular function: MOST trial findings relevant to leadless pacemakers. Pacing and Clinical Electrophysiology. 43(12). 1461–1466. 1 indexed citations
9.
Case, Amy Hajari, Anne S. Hellkamp, Megan L. Neely, et al.. (2020). Associations between Patient-reported Outcomes and Death or Lung Transplant in Idiopathic Pulmonary Fibrosis. Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry. Annals of the American Thoracic Society. 17(6). 699–705. 18 indexed citations
10.
Poole, Jeanne E., Brian Olshansky, Daniel B. Mark, et al.. (2020). Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFT. Journal of the American College of Cardiology. 76(4). 405–415. 51 indexed citations
11.
Khariton, Yevgeniy, Gregg C. Fonarow, Anne S. Hellkamp, et al.. (2020). Heterogeneity of Health Status Treatment Response with Sacubitril/Valsartan: Insights from the CHAMP-HF Registry. ESC Heart Failure. 8(1). 710–713. 3 indexed citations
12.
Pokorney, Sean D., Eric Black‐Maier, Anne S. Hellkamp, et al.. (2020). Oral Anticoagulation and Cardiovascular Outcomes in Patients With Atrial Fibrillation and End-Stage Renal Disease. Journal of the American College of Cardiology. 75(11). 1299–1308. 31 indexed citations
13.
Kaufman, Brystana G., Shreyansh Shah, Anne S. Hellkamp, et al.. (2020). Disease Burden Following Non-Cardioembolic Minor Ischemic Stroke or High-Risk TIA: A GWTG-Stroke Study. Journal of Stroke and Cerebrovascular Diseases. 29(12). 105399–105399. 11 indexed citations
14.
Snyder, Laurie D., Christopher L. Mosher, Colin Holtze, et al.. (2020). Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO Registry. BMJ Open Respiratory Research. 7(1). e000567–e000567. 18 indexed citations
15.
Khariton, Yevgeniy, Gregg C. Fonarow, Suzanne V. Arnold, et al.. (2019). Association Between Sacubitril/Valsartan Initiation and Health Status Outcomes in Heart Failure With Reduced Ejection Fraction. JACC Heart Failure. 7(11). 933–941. 34 indexed citations
16.
Zullig, Leah L., Tracy Y. Wang, Anne S. Hellkamp, et al.. (2019). Novel application of approaches to predicting medication adherence using medical claims data. Health Services Research. 54(6). 1255–1262. 18 indexed citations
17.
Doll, Jacob A., Anne S. Hellkamp, Laine Thomas, et al.. (2015). Effectiveness of cardiac rehabilitation among older patients after acute myocardial infarction. American Heart Journal. 170(5). 855–864. 67 indexed citations
18.
Steinberg, Benjamin A., Anne S. Hellkamp, Yuliya Lokhnygina, et al.. (2014). Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial. European Heart Journal. 36(5). 288–296. 237 indexed citations
19.
Zeitler, Emily P., Jonathan P. Piccini, Anne S. Hellkamp, et al.. (2014). Exercise Training and Pacing Status in Patients With Heart Failure: Results From HF-ACTION. Journal of Cardiac Failure. 21(1). 60–67. 18 indexed citations
20.
Pun, Patrick H., Anne S. Hellkamp, Gillian D Sanders, et al.. (2014). Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort study. Nephrology Dialysis Transplantation. 30(5). 829–835. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026